Telemark Asset Management LLC significantly reduced its stake in Biodesix, Inc. (NASDAQ:BDSX) by 95.0% in Q3, selling over 7.8 million shares and retaining 414,124 shares. Despite this large reduction by one fund, corporate insiders have been active with both sales and purchases, and institutional ownership remains at nearly 21%. Analysts generally maintain a “Moderate Buy” consensus with a $32.50 target price for Biodesix.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Telemark Asset Management LLC Trims Position in Biodesix, Inc. $BDSX
Telemark Asset Management LLC significantly reduced its stake in Biodesix, Inc. (NASDAQ:BDSX) by 95.0% in Q3, selling over 7.8 million shares and retaining 414,124 shares. Despite this large reduction by one fund, corporate insiders have been active with both sales and purchases, and institutional ownership remains at nearly 21%. Analysts generally maintain a “Moderate Buy” consensus with a $32.50 target price for Biodesix.